Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

399
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
399
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters00:54

Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters

70
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
70
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

647
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
647
Two-Compartment Open Model: Extravascular Administration01:12

Two-Compartment Open Model: Extravascular Administration

158
The two-compartment model for extravascular administration represents a drug's absorption and distribution process. It features a central compartment, where the drug is first absorbed, and a peripheral compartment, which illustrates the drug's distribution throughout the body. The rate of change in drug concentration in the central compartment is calculated by three exponents: absorption, distribution, and elimination.
The absorption exponent (ka) indicates the speed at which the drug...
158
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

214
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
214
Bioavailability: Overview01:13

Bioavailability: Overview

2.7K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spinal Cord and Central Nervous System Distribution of Epidural Oxycodone-Experimental Pregnant Sheep Model.

Acta anaesthesiologica Scandinavica·2026
Same author

The performance of plasma pTau181 and pTau217 in distinguishing Alzheimer's disease from various neurodegenerative disorders, psychiatric disorders, and cognitively unimpaired controls.

Journal of Alzheimer's disease : JAD·2026
Same author

Resilience and health-related quality of life in patients with pulmonary diseases receiving ambulatory oxygen therapy - 24-month follow-up results.

BMC pulmonary medicine·2025
Same author

Effect of ventricular volume on cerebrospinal fluid Alzheimer's disease biomarkers in patients with idiopathic normal pressure hydrocephalus.

Journal of Alzheimer's disease : JAD·2025
Same author

Procalcitonin in neonatology and paediatrics-Use and physicians' perceptions in Finland between 2016 and 2021.

Acta paediatrica (Oslo, Norway : 1992)·2024
Same author

Tramadol-paracetamol for postoperative pain after spine surgery - A randomized, double-blind, placebo-controlled study.

Scandinavian journal of pain·2024

Related Experiment Video

Updated: Jun 9, 2025

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.3K

Comparison of Vancomycin AUC24 Calculation Methods for Neonates and Infants.

Tuomas Laitila1, Ulla Sankilampi2,3, Marjo Renko2,3

  • 1Kuopio University Hospital Pharmacy, Kuopio, Finland.

European Journal of Drug Metabolism and Pharmacokinetics
|October 22, 2024
PubMed
Summary

The Sawchuk-Zaske method accurately estimates vancomycin AUC24 in neonates and infants. Bayesian forecasting improved with modified residual error models for vancomycin (AUC24) estimation.

More Related Videos

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

28.9K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.5K

Related Experiment Videos

Last Updated: Jun 9, 2025

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

1.3K
A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically
11:28

A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically

Published on: September 9, 2015

28.9K
Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

4.5K

Area of Science:

  • Pharmacokinetics
  • Pediatric Pharmacology
  • Drug Monitoring

Background:

  • Intermittent vancomycin infusions are common for neonates and infants.
  • Area under the concentration-time curve during 24 hours (AUC24) is crucial for vancomycin dosing.
  • Bayesian forecasting is often used to estimate AUC24, but simpler methods are needed.

Purpose of the Study:

  • Compare AUC24 estimates from the Sawchuk-Zaske method and two Bayesian models.
  • Evaluate the utility of the Sawchuk-Zaske method in pediatric populations.
  • Assess the impact of modified residual error models in Bayesian forecasting.

Main Methods:

  • Retrospective analysis of AUC24 values in 18 neonates and infants.
  • Comparison of Sawchuk-Zaske method, traditional compartmental analysis (reference), and two Bayesian models.
  • Application of original and modified residual error models for Bayesian forecasting.

Main Results:

  • Sawchuk-Zaske method showed minimal difference (-2.7% to 0.9%) compared to the reference method.
  • Bayesian forecasting with original models achieved <15% difference in 33-61% of cases.
  • Modified Bayesian models improved accuracy, with 72-83% of estimates within <15% of the reference.

Conclusions:

  • The Sawchuk-Zaske method is a practical and accurate tool for vancomycin AUC24 estimation in neonates and infants.
  • Bayesian forecasting models demonstrate improved accuracy with reduced residual error.
  • Both methods offer valuable approaches for optimizing vancomycin therapy in pediatric patients.